Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication‐overuse headache-Reference-Cited by-同舟云学术

Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication‐overuse headache

Published:2021-09-22 Issue:9 Volume:61 Page:1421-1431
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache: The Journal of Head and Face Pain

Author:

Marmura Michael J.¹,Diener Hans‐Christoph²,Cowan Robert P.³,Tepper Stewart J.⁴,Diamond Merle L.⁵,Starling Amaal J.⁶,Hirman Joe⁷,Mehta Lahar⁸,Brevig Thomas⁹,Cady Roger¹⁰

Affiliation:

1. Department of Neurology Jefferson Headache Center Thomas Jefferson University Philadelphia Pennsylvania USA

2. Institute for Medical Informatics, Biometry and Epidemiology Medical Faculty University of Duisburg‐Essen Essen Germany

3. Department of Neurology and Neurological Sciences Stanford University Headache and Facial Pain Program Palo Alto California USA

4. Department of Neurology Geisel School of Medicine at Dartmouth Hanover New Hampshire USA

5. Diamond Headache Clinic Chicago Illinois USA

6. Department of Neurology Mayo Clinic Phoenix Arizona USA

7. Pacific Northwest Statistical Consulting, Inc. Woodinville Washington USA

8. Lundbeck Seattle BioPharmaceuticals, Inc. Bothell Washington USA

9. H. Lundbeck A/S Copenhagen Denmark

10. Lundbeck La Jolla Research Center San Diego California USA

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/head.14206

Reference38 articles.

1. Pathophysiology, prevention, and treatment of medication overuse headache

2. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

3. The cost of headache disorders in Europe: the Eurolight project

4. Health and quality of life in patients with medication overuse headache syndrome after standardized inpatient rehabilitation

5. Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project)

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medication-Overuse Headache: Update on Management;Life;2024-09-11

2. Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial;Neurology;2024-07-23

3. CGRP Modulating Therapies: An Update;Current Neurology and Neuroscience Reports;2024-07-17

4. Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache;Headache: The Journal of Head and Face Pain;2024-06-24

5. Effectiveness and tolerability of eptinezumab in treating patients with migraine resistant to conventional preventive medications and CGRP (receptor) antibodies: a multicentre retrospective real-world analysis from Germany;The Journal of Headache and Pain;2024-05-16